An Unauthorized Modern Vaccines Timeline
A history of vaccines here collected from various sources (excluding mRNA vaccines)
1900-Albert Calmette and Camille Guérin began their research for an antituberculosis vaccine at the Pasteur Institute in Lille. By 1913 they were prepared to initiate a vaccination trial in cattle which was interrupted by outbreak of World War I.
1901- nine children in New Jersey died from contaminated smallpox vaccine, setting the stage for the adoption of rigorous standards for the emerging biological products industry.
1914-MV (mixed virus) strain of the Rockefeller Institute in NY, a virulent virus mixture prepared by H. L. Amoss in 1914 and kept for decades through numerous intracerebral passages in monkeys .
1916- NY Polio epidemic. The number of children age 2 yr affected was the highest ever recorded; the case fatality rate of 25% was the highest ever recorded [certainly higher than natural wild type polio virus which is less than one percent]; the epidemic started in early May, well before the normal summer polio season.
The virus was highly destructive to the nervous system, much like the Rockefeller labs cultivated “MV” strain. Three miles from the epicentre of the outbreak, Simon Flexner and his associates at the Rockefeller Institute had been passaging spinal cord tissue containing poliovirus, from one Rhesus monkey spinal cord to another.
1917 - A report from the Rockefeller Institute states:
“Reference should be made that before the United States entered the war the Institute had resumed the preparation of anti-meningococcic serum, in order to meet the requests of England, France, Belgium Italy and other countries.”
An outbreak of epidemic meningitis at Camp Funston, Kansas, in October and November, 1917
1918-Spanish Flu/vaccine experiments.Between January 21st and June 4th of 1918, Dr. Gates reports on an experiment where soldiers were given 3 doses of a bacterial meningitis vaccine serum made in horses.
By March of that year, “100 men a day” were entering the infirmary at Fort Riley. The soldiers developed flu-like symptoms. Bacterial meningitis, then and now, is known to mimic flu-like symptoms.
1921, Calmette decided that the time was ripe for a trial of the vaccine in man. The first human administration of BCG was by Benjamin Weill-Halle (1875-1958)
From 1924 to 1928, 114 000 infants were vaccinated without serious complications . The statistics of Calmette and Guerin showed a fall in tuberculosis mortality among those susceptible infants who had been vaccinated with BCG.
1920’s -diphtheria toxoid and pertussis vaccine developed. The first definitive experiments with pertussis vaccine were conducted .
1922-Dr. James Gordon Cumming stated in article in the Journal of the American Medical Association that sanitation would eliminate the threat of diphtheria.
1930 -disaster in Lübeck shattered confidence in BCG. Of 250 vaccinated, there were 73 deaths in the first year and another 135 were infected but recovered. The German government set up an inquiry.
After 20 months their report exonerated BCG as the cause of the disaster, which they attributed to negligent contamination of the vaccine by virulent tubercle bacilli in the Lübeck laboratories
1931- Rockefeller Foundation mouse-monkey cultured yellow fever vaccinations started for travelers to regions having high incidence of Yellow Fever
1934-Dr Brodie develops polio vaccine and begins trial while working for the New York Public Health Department with funding by the Rockefeller Foundation.
Maurice Brodie had used ingenious techniques to reproduce poliovirus in mice for vaccine trials. Called the Brodie vaccine it was given in trials to children in North Carolina and staff at LA County Hospital. Nine children who received the vaccine had died.
The MV strain was used by Brodie and Park for their vaccines .
Surprisingly, all of the polio histories have accepted the idea that this MV strain caused the polio cases associated with the experimental vaccines, none has suggested that the earlier and presumably less altered virus might be linked with the 1916 epidemic.
1934-LA County Hospital - outbreak said to be atypical polio affecting 12% of nurses/doctors.
The first outbreak of what would later be rebranded “chronic fatigue syndrome” started at Los Angeles County General Hospital in the late spring of 1934..
This ME/ CFS outbreak followed a polio outbreak on the West Coast in which 2,449 suspected cases were seen at Los Angeles County General Hospital.
Dr Gilliam was an assistant surgeon at the US Public Health Service who had been working on studying the efficacy of the Brodie Vaccine issued a paper describing the outbreak.
His description of the acute and subacute characteristics of M.E./ CFS and its epidemiological factors, but his book also implicitly posed a question that has been avoided and unanswered to this day.
Did the 198 health care workers fall ill, or remain ill, solely as a result of the “prophylactic serum” that Gilliam persistently documents as having been given, often prior to any symptom, to the majority of patients in this epidemic?
The serum was an early polio vaccine grown in mouse tissue and given with an accompanying immune system booster (adjuvant) preserved with the mercury preservative thimerosal.
His published paper made no mention of the serum but according to Dr Hyde this was because he was forced to remove it by by his bosses at the Public Health Service who feared a backlash against vaccines.
1954, the same year that the Salks Polio Vaccine was introduced, the CDC abruptly redefined “paralytic polio” much more narrowly, to apply to only the most severe cases in which paralysis continued for at least 60 days
Milder cases of of what were called “polio” included a variety of other paralytic ailments, such as enterovirus infections; poisoning with neurotoxins such as lead, arsenic, and DDT; transverse myelitis; other types of viral or “aseptic” meningitis; and Guillain-Barré syndrome
DDT spraying of residents and residential areas were also reduced due to safety concerns, and the March of Dimes program paying for Polio treatments that encouraged a Polio diagnosis was curtailed
1954-Dr. Bernice Eddy was an award-winning virologist, and one of the highest-ranking female scientists in NIH history.
In 1954, NIH asked Eddy to direct testing of the Salk polio vaccine. She discovered, while testing eighteen macaques, that Salk’s vaccine contained residual live polio virus that was paralyzing the monkeys.
Dr. Eddy warned her NIH bosses that the vaccine was virulent, but they dismissed her concerns. The distribution of that vaccine by Cutter Labs in California caused the worst polio outbreak in history.
Less than a month after the Salk vaccine's approval and licensure in April 1955, it became apparent that some of the vaccine lots were contaminated with wild polio.
The ensuing disaster, in which some 260 children developed paralytic polio from the vaccine, was widely blamed at the time on Cutter pharmaceuticals.
The Cutter Incident was a defining moment in the history of vaccine manufacturing and government oversight of vaccines, and led to the creation of a better system of regulating vaccines.
After the government improved this process and increased oversight, polio vaccinations resumed in the fall of 1955.
In 1954, while the national field trials of Jonas Salk's polio vaccine captivated media attention, Enders and pediatrician Thomas Peebles successfully cultivated measles virus in human kidney cell culture for the first time. Enders had earlier isolated the Polio virus for which he received a Nobel Prize
Enders decided to play a much more “hands-on” role with measles vaccine than he had with polio. He was unhappy with how the polio vaccine saga had unfolded after he had left its development to others.
Enders believed Salk's inactivation process had been at fault. He wanted to stay personally involved to be sure that the measles vaccine's development would proceed more smoothly.
1955 researchers engaged in two decades of experimentation on mentally disabled children at New York’s Willowbrook State School, intentionally infecting children with hepatitis to further vaccine development.
1957-experimental oral polio vaccines were manufactured and administered to over one million Africans from 1957 to 1960. These experiments were led by Dr. Hilary Koprowski, director of the Wistar Institute in Philadelphia.
Koprowski viewed himself as Dr. Sabin’s competitor in the race to replace the Salk vaccine. Both Sabin’s and Koprowski’s vaccines were grown in monkey kidney tissue..
“Between 1956 and 1960 more then 1 million African people were ‘encouraged’ to receive Koprowski’s vaccine called CHAT.”. The earliest known cases of AIDS occurred in central Africa, in the same regions where Koprowski’s polio vaccine was given to over a million people in 1957-1960.
There is no documented case of HIV infection or AIDS before 1959. Polio vaccines are grown (cultured) on monkey kidneys which could have been contaminated by SIVs. Polio vaccines could not be screened for SIV contamination before 1985.
1957-BMJ.com rapid response dated 26 August 2012 (Eradication of polio by vaccination Part 3), Morris et al. (1956) isolated and identified monkey cytopathogenic agent that produced acute respiratory illness in chimpanzees at the Walter Reed Army Institute of Research and named it chimpanzee coryza virus (CCV).
Chanock et al.(1957) pointed out the association of a new type of cytopathogenic myxovirus with infantile croup. Chanock and Finberg (1957) reported on two isolations of similar agents from infants with severe lower respiratory illness (bronchopneumonia, bronchiolitis and laryngotracheobronchitis).
The two viruses were indistinguishable from an agent associated with the outbreak of coryza in chimpanzees (Chimpanzee coryza agent or CCA virus, studied by Morris et al. (1956).
A person working with the infected chimpanzees (CCA virus of Morris et al. as above) subsequently experienced respiratory infection with a rise in CCA antibodies during convalescence.
A new name was proposed for this agent:”respiratory syncytial virus” (RSV). The original name “chimpanzee coryza virus” disappeared from medical literature.
In Australia, Lewis et al. (1961) isolated further viral specimens identical with CCA. They wrote, “Prior to July 1960, the influenza and parainfluenza viruses predominated in infant epidemic respiratory infections.
In July 1961 the pattern changed abruptly with sudden increases in bronchiolitis and bronchitis, infrequent before. 58% were under 12 months, and patients under 4 years predominated. Infants with bronchiolitis and severe bronchitis yielded RCA not previously isolated. Deaths have occurred.”
1960-it was discovered that Simian Virus 40 (SV40) contaminated up to 30% of the poliovirus vaccines in the US. This contamination arose because the vaccines were produced in monkey kidney cell cultures harboring SV40 between 1955 and 1963.
During this period, approximately 90% of children and 60% of adults in the USA were inoculated for polio and possibly exposed to SV40. Contaminated vaccines were allowed to be given until stocks were depleted in 1963
New York Cancer Society had invited Eddy to address its annual conference. Eddy chose the subject of tumors induced by the polyoma virus. However, she also described tumors induced by the SV40 viral agent in monkey kidney cells.
Her NIH supervisor angrily reprimanded Eddy for mentioning the discovery publicly and banned her from public health crisis statements. Eddy argued for publication of her work on the virus, casting the contaminated vaccine supply on an urgent public health crisis.
Agency bigwigs stonewalled publication, allowing Merck and Parke-Davis to continue marketing the oncogenic vaccine to millions of American adults and children.
On July 26, 1961, the New York Times reported that Merck and Parke-Davis were withdrawing their Polio vaccines. The article said nothing about cancer. The Times ran the story next to an account about overdue library fines on page 33.
NIH officials refused to pursue a total recall of the rest of the supply, fearing reputational injury to the vaccine program if Americans learned that PHS had infected them with a cancer-producing virus.
As a result, millions of unsuspecting Americans received carcinogenic vaccines between 1961 and 1963. The Public Health Service then concealed that “secret” for forty years.
1962 President John F. Kennedy Jr signed the Vaccination Assistance Act, the first law directing federal funds to states for broad immunization efforts, with an emphasis on children. Under President Lyndon B. Johnson, architect of the era’s Great Society reforms, Congress in 1965 renewed the program and extended it to cover measles.
1960’s -Working on the Measles Vaccine in the 1950’s Enders and Katz approached the Walter E. Fernald State School near Waltham, Massachusetts where they had obtained sampled that led to the isolation of the measles virus inn1954
This was an institution typical of many others of the time that provided long-term custodial and medical care for severely handicapped children with conditions such as microcephaly, trisomy and cerebral palsy.
“They lived in dormitories,” Katz recollected, “and they had really severe outbreaks of measles every few years—not just with morbidity, but with mortality.”
Conducting a clinical trial among institutionalized children raised significant ethical questions. Indeed, just 10 years earlier, the Fernald School had permitted nontherapeutic nutritional studies without informing families that their children were being given radioisotopes.
Given that research ethics in the 1950s remained largely unregulated, some historians have argued that the Nuremberg code's powerful articulation of informed consent in 1946 had little impact on American research until the 1960s.
In this light, it is notable that Katz explained the trial in person to every parent, and the ensuing article clearly stated that no child was given the vaccine without written parental consent.
After demonstrating its safety and efficacy, first in monkeys and then humans, John Enders and colleagues declared their measles vaccine capable of preventing infection.
Their live Edmonston-B strain of measles virus was transformed into a vaccine licensed in the United States in 1963, produced by Merck (Rubeovax), and nearly 19 million doses would be administered over the next 12 years.
The vaccine proved to be to reactogenic with 30% to 40% of these children showed signs of temporary high fever and a rash after vaccination, side effects could be reduced by coadministration ofgamma globulin
Gamma globulin comes with a risk that are common to all pooled human blood products given the screening capabilities at the time
Attempts were made to develop further attenuated, less reactogenic strains continued. (The Schwarz strain would be licensed in 1965, and Merck’s more attenuated “Moraten” strain in 1968.)
At the same time a formalin-inactivated one produced by Pfizer (Pfizer-Vax Measles–K) was licensed.
Although most people were initially protected by the formalin-inactivated vaccine, the relatively low-avidity antibodies elicited by this vaccine failed to protect at lower titers and led to a severe form of illness known as atypical measles, in immunized individuals exposed to wild-type virus
Children with atypical measles presented with high fever, a petechial rash in the extremities, and bibasilar pneumonia . In this case, low-avidity antibodies elicited by the vaccine failed to neutralize virus that bound to the CD150 high-affinity receptor in exposed individuals, and promoted immune complex-mediated illness at sites of measles virus infection, mainly the skin and lungs . Importantly, atypical measles occurred many years after exposure to the formalin-inactivated vaccine.
After observing the first cases of atypical measles, formalin-inactivated vaccine was withdrawn and recipients not yet exposed to wild-type measles were inoculated with the licensed live-attenuated vaccine, with the intent of generating protective antibodies to prevent further atypical cases.
These individuals developed an erythematous nodule at the subcutaneous injection site, characterized histopathologically by measles virus-specific immune complexes .
Some failed to mount a corrective immune response following the live-attenuated vaccination, presumably due to neutralization of the vaccine-strain virus by pre-existing antibodies.
In most however, the live attenuated vaccine successfully induced a high affinity IgG response that could outcompete the potentially pathogenic antibodies and provide long-term protection
1967, President Johnson endorsed CDC’s plan to eliminate measles from the United States within a year.
1967-infants and toddlers immunized with a formalin-inactivated vaccineagainst respiratory syncytial virus(RSV) experienced an enhanced form of RSVdisease characterized by high fever, bronchopneumonia, and wheezing when they became infected with wild-type virus in the community
Levy et al. (1997) ascertained that respiratory syncytial virus (RSV) became the most prevalent cause of lower respiratory tract infections (LRTI) in infants and young children. “Infections with RSV are a major health problem during early childhood and primary RSV infections occur most often between the ages of 6 weeks and 2 years.
Approximately one half of all infants became infected with RSV during the first year of life…In the US each year approximstely100,000 children are hospitalised at an estimated cost of $300 million. More than half of those admitted for RSV bronchiolitis are between 1 and 3 months of age”
To quote Simoes (1999), “Since it [RSV] was identified as the agents causing chimpanzee coryza in 1956, and after its subsequent isolation from children with pneumonary disease in Baltimore,USA, respiratory syncytial virus (RSV) had been described as the single most important virus causing acute respiratory tract infections in children.
The WHO estimates that of the 12.2 million annual deaths in children under 5 years, a third are due to acute infections of the lower respiratory tract. Streptococcus pneumoniae, Haemophilus influenzae, and RSV are the predominant pathogens…vaccinated children were not protected from subsequent RSV infection.
Furthermore, RSV-naïve infants who received formalin-inactivated RSV vaccine, and who were naturally infected with RSV later, developed more severe disease in the lower respiratory tract than a control group immunized with a trivalent parainfluenza vaccine.”…
Data from ten developing countries with intense polio vaccination showed RSV the most frequent cause of lower respiratory tract infections (70% of all cases).”
The yearly cost of bronchiolitis in the USA goes into billions.
Johnson et al. (2014) write, “Respiratory syncytial virus (RSV) is a major cause of disease and hospitalisations in infants and young children worldwide, resulting in more than 3.4 million hospitalisations and more than 200,000 deaths globally. Medically attended RSV pediatric disease in the USA exceeds $1 billion in direct medical costs annually.
RSV infections also cause significant mortality and morbidity in the elderly and other high risk adults.”… “Clinical trials of a formalin-inactivated RSV vaccine (F1-RSV) in young infants did not protect against infection, but increased disease severity…
Progress has been hampered by limited immunogenicity, induction of Th2-biased immunity or unacceptable levels of adverse events. Natural RSV infection does not induce long-term protection, possibly due to the ability of RSV to suppress or evade host immunity.”
1968 Merck began to distribute an improved vaccine using John Enders’s measles strain, developed by Maurice Hilleman and colleagues. Although the previous vaccine was effective in preventing future measles infections, it had to be given along with gamma globulin—human blood proteins—in order to reduce side effects.
Hilleman eliminated the need for giving gamma globulin with the vaccine by passing the virus through chick embryo cells an additional 40 times, weakening it even further. Called the Moraten strain (More Attenuated Enders), it has been the only measles vaccine used in the United States since licensure
1969-Three rubella vaccines are licensed in the United States: HPV-77 (grown in dog kidney), HPV-77 (grown in duck embryo), and Cendehill (grown in rabbit kidney). Many states add rubella vaccines to the list of immunizations required for school entry
Because the HPV-77 dog kidney vaccine appeared to be associated with a higher proportion of such adverse events, the vaccine was eventually withdrawn from the market in the United States and other countries.
1972 The U.S. government licensed Merck’s measles, mumps, and rubella combination vaccine (M-M-R). In an article published in the Journal of the American Medical Association, researchers reported that the vaccine induced immunity to measles in 96% of vaccinated children; to mumps in 95%; and to rubella in 94%.
Additionally, initial tests in 1968 had already shown that adverse reactions from the MMR vaccine were no greater than from any of the single vaccines
1973-live bacterial viruses(bacteriophages) were identified in several lots of live viral vaccines that had been submitted by Merck to the Bureau of Biologics (BB), Food and Drug Administration (FDA) for lot release Bacteriophages were reported as a contaminant of bovine sera in 1972
By 1969, 17 states had added measles to their compulsory immunization laws; a decade later, all of them had.The final push had come from President Jimmy Carter’s administration, whose multipronged National Childhood Immunization Initiative, launched in 1977, funneled federal resources to states to encourage mass immunization and asked governors to ensure their immunization laws covered all recommended vaccines—a list that by then comprised polio, diphtheria, pertussis, tetanus, mumps, rubella, and measles.
1976 there was a small increased risk of a serious neurological disorder called Guillain-Barré Syndrome (GBS) following vaccination with a swine flu vaccine. The increased risk was approximately 1 additional case of GBS for every 100,000 people who got the swine flu vaccine.
When over 40 million people were vaccinated against swine flu, federal health officials decided that the possibility of an association of GBS with the vaccine, however small, necessitated stopping immunization until the issue could be explored.
The Institute of Medicine (IOM) conducted a thorough scientific review of this issue in 2003 and concluded that people who received the 1976 swine influenza vaccine had an increased risk for developing GBS.
1978- the CDC conducted a hepatitis B vaccine trials on homosexual men living in New York City, San Francisco and Los Angeles.
Dissidents who have studied the available published data are convinced that this trial precipitated the devastating AIDS epidemic in America’s homosexual community.
Before these CDC experiments there were no reported cases of HIV or AIDS in America. The AIDS epidemic was officially declared by CDC in 1981, at the conclusion of the trials.
Yet, in the NEJM published report (1980) researchers proclaimed the vaccine “safe and incidence of side effects low,” and claimed a 96% success rate. They failed to mention the emergence of a new disease affecting some of the subjects.
Between 1978 and 1980, 359 homosexual and bisexual men were recruited from the San Francisco municipal sexually transmitted disease clinic for hepatitis B vaccine trials.
Of the 359 participants, 320 (89%) consented to have their stored blood samples tested for human immunodeficiency virus antibodies.
The prevalence of human immunodeficiency virus infection in these 320 vaccine trial participants rose from 0.3% in 1978 to 50.9% in 1988.
The men in the Manhattan experiment had the highest rate of HIV ever recorded for that time period: based on stored blood samples 20% were discovered to be HIV-positive in 1980, and over 40% in 1984.
In addition, a re-examination of the stored blood samples from an AIDS trial in NYC by epidemiologists at the National Cancer Institute in 1999, found that one out of five gay men (20%) tested positive for the new KS herpes-8 virus (Kaposi’s Sarcoma virus in 1982).
Before 1978 no stored blood anywhere in the US tested positive for either HIV or the Kaposi’s Sarcoma virus (which was not identified until 1994).
The hepatitis B vaccine was developed by Saul Krugman of New York University, in collaboration with Hilleman at MSD and R.H. Purcell at NIAID (a division of the National Institutes of Health).
Krugman became infamous in the 1970s, when it came out that he had deliberately infected retarded children institutionalized at Willowbrook in New York City with hepatitis B virus, using the pretext that conditions there were so atrociously unsanitary, that the children would be- come infected anyway! NYU was one of the institutions that got money from the 1969 grant of $10 million for biowarfare.
(1969-Pentagon official Donald MacArthur on June 9 requested $10 million to develop, over the next 5 to 10 years, a new, contagious microorganism which would destroy the human immune system. Such research could be categorized as “defensive" as in order to defend oneself against a possible new virus, one must first develop the virus.)
1979-Meetings are held at the Food and Drug Administration (FDA) Bureau of Biologics and at the CDC to discuss reports of sudden infant death syndrome (SIDS) in Tennessee following pertussis vaccination.
No evidence of a causal relationship is found. Wyeth Laboratories, the manufacturer, withdraws the questioned vaccine lot nonetheless (Coulter and Fisher, 1985).
1978- Two lawsuits are filed in U.S. courts alleging that children were harmed by pertussis vaccine (Koplan and Hinman, 1987).
1981-By Carter’s last year in office , 96% of all schoolchildren were vaccinated against measles—an all-time high—and the number of measles cases—2600—was at an all-time low
Three commercial manufacturers of diphtheria and tetanus toxoids and pertussis vaccine, adsorbed (DTP vaccine) indicated a striking increase in the number of lawsuits filed against them alleging damage caused by the vaccine.
Only one such case was filed in 1978, whereas 73 were filed in 1984. During the seven-year period from 1978 to 1984, the average amount claimed per suit has risen from $10 million to $46.5 million. If the current trend continued, suits would pose an increasing threat to the availability of DTP vaccines in the United States.
Vaccine Roulette,” a 1982 NBC news documentary by consumer reporter Lea Thompson, whose previous work had exposed the dangers of asbestos-lined hair-dryers and nutrient-deficient infant formulas.
An hour-long investigation focused on the pertussis component of the diphtheria-pertussis-tetanus vaccine, “Vaccine Roulette” depicted physicians in disagreement about vaccine safety, parents devastated by vaccine injuries to their children, and terrifying statistics on vaccine injury risk, including that 1 in 7000 children had serious adverse effects ranging from high fevers and seizures to brain damage and death after diphtheria-pertussis-tetanus vaccination.
The documentary reflected a fear pervasive among the vaccine hesitant: that vaccination was an unexamined but potential cause of the rising number of developmental and learning disabilities in children. In the context of the time, the reporters’ job was to investigate medical science, not laud it, and Thompson, a female reporter in a field dominated by men, did just that.
The “medical establishment,” she reported on air, had been “aggressive in promoting…the most unstable, least reliable vaccine we give our children.”
“Vaccine Roulette” gave voice to parents who had been expressing vaccine worries for the preceding decade. It also marked the start of a decade in which 2 typically opposing ideologies (those favoring big government and those opposed to it) found common ground in the issue of childhood vaccination.
“Vaccine Roulette” inspired the formation of a vaccine-safety advocacy group in the Washington, DC, area: Dissatisfied Parents Together, DPT for short.
DPT (now the National Vaccine Information Center) mobilized a coalition of supporters to win passage of the 1986 National Childhood Vaccine Injury Act,which required the federal government to inform parents of vaccine benefits and risks, required vaccine providers to report vaccine injuries to federal authorities, and established the National Vaccine Injury Compensation Program.
For its vaccine-critical supporters, more government was needed to guard against the pitfalls of the new era of mandatory vaccination.
However, little did they realize that liability exemption given vaccine makers would unleash Pandoras Box and cause an explosion in vaccines rushed to market with captured regulatory agencies to ensure their safety
1986 the National Childhood Vaccine Injury Act was passed which resulted in an explosion of the vaccine schedule. Today 54% of American children have serious chronic health conditions according to a 2011 survey funded by the U.S. Department of Health and Human Services (HHS). Conditions include neuro -developmental disorders, asthma, allergies, mental health/behavioral disorders and obesity. For American kids born in 1986, only 12.8% had chronic diseases.
Despite the world’s most aggressive vaccine schedule we now rank 35th in overall health outcomes—just behind Costa Rica, making the U.S., by most measures, including infant mortality, the sickest nation in the developed world.
The 1986 Act frees companies from liability for injuries resulting from childhood vaccines. The act created the National Vaccine Injury Compensation Program (NVICP) that is governed by HHS. Over $4.2 billion has been paid by consumers for vaccine injuries (every vaccine has an excise tax for this purpose). The U.S. vaccine schedule has more than tripled since the 1986 Act.
An HHS-sponsored study by the Agency for Healthcare Research and Quality found that vaccine injuries, when tracked using electronic medical records, occurs in 1 in 39 vaccines given.
The Vaccine Adverse Event Reporting System (VAERS), where doctors and patients voluntarily report adverse vaccine events, received 58,381 reports in 2018, including 412 deaths, 1,237 permanent disabilities, and 4,217 hospitalizations. An HHS-funded review of VAERS concluded that “fewer than 1% of vaccine adverse events are reported” to VAERS. The CDC has refused to mandate or automate VAERS reporting. So multiply the numbers by 100 and thats 40,000 dead in 30 years and 4 million hospitalizations. Autism and other chronic diseases are probably even more underreported.
The Supreme Court ruled in 2011 that vaccines are unavoidable unsafe in upholding their protection from liability. So much for the CDC and Industries claim that vaccines are safe.
None of the vaccines on the U.S. CDC recommended childhood vaccine schedule were tested against an inert saline placebo in clinical trials. None have been compared against a control group of unvaccinated populations. None have been subject to long term follow up. No study has been conducted evaluating safety of vaccines given according to CDC schedule. None have been tested for their carcinogenicity or safety in pregnant women. Their claim vaccines are safe is the alleged absence of evidence they are unsafe . The absence of evidence is not evidence of absence. The approach to funding for safety studies follows a “dont look, dont find” mentality.
Vaccines are regulated by the FDA as “biologics” and are not always put through the same level of safety testing as new pharmaceuticals. Pre-licensing clinical trials are sometimes as short as a few days or weeks, making it impossible to evaluate longer-term outcomes such as autoimmune illness or cancer. Clinical trials for Merck’s Recombivax hepatitis B vaccine administered on the first day of life monitored fewer than 150 infants and children and for just five days after each dose.
Congress—included in the 1986 Act, recognizing that drug companies no longer had any incentive to make vaccines safe—an order for HHS to study vaccine injuries, work to improve vaccine safety, and report to Congress on its progress every two years. It has not sent one safety report to Congress in over 30 years. Congress seems content to ignore the flaunting of their own laws.
1987-Dr. Maurice Hilleman, Merck’s foremost vaccine developer acknowledged that the polio vaccine (manufactured by Merck) had been contaminated with SV40. He also seemed to suggest that SV40 is the source of AIDS: “I didn’t know we were importing AIDS.”
He nevertheless defended the contaminated vaccine stating: “it was good science at the time because that was what you did. You didn’t worry about these wild viruses…”
The taped interview was never aired for fear of liability; but it was submitted to the Library of Congress and in 2011 was posted on YouTube which has since been censored.
1990-In an experiment to find out if they could give a high potency Edmonston Zagreb measles vaccine to babies as young as four months old in order to overwhelm their natural maternal antibodies and replace them with vaccine-induced antibodies,.....
https://www.nvic.org/nvic-archives/newsletter/vaccinereactionjune1996.aspx
medical researchers at the Centers for Disease Control (CDC) and Johns Hopkins University injected thousands of babies in the Third World with the experimental vaccine that reportedly caused chronic immune suppression and the deaths of an unknown number of babies.
With the help of Kaiser Permanente, more than 1500 six month old black and Hispanic babies in inner city Los Angeles were enrolled in the experiment starting in June 1990.
The study was halted in October 1991 after repeated reports from vaccine trial sites in Africa that girl babies were dying in higher than expected numbers six months to three years after vaccination.
CDC Admits Informed Consent Violations - CDC director David Satcher admitted in a June 17 Los Angeles Timesarticle that a National Institutes of Health (NIH) investigation of the 1990-91 Los Angeles study found that informed consent regulations had been violated because the parents were not told their babies would be injected with an experimental vaccine that had never been licensed by the FDA for use in America.
Both Kaiser and the CDC have denied that any of the Los Angeles babies were harmed by the high potency EZ vaccine but did admit that one child, who received a standard potency EZ vaccine, died from a bacterial infection they maintain is unrelated to the vaccination.
1992-soldiers returning from Gulf War experiencing GWS. GWS soldiers were heavily inoculated with vaccines that contained mercury [thimerosal] preservatives plus aluminum and squalene adjuvants) including an experimental anthrax vaccine using squalene as an adjuvant
Gulf War Syndrome (GWS) is a multisystemic illness afflicting many Gulf War-era veterans. A 2000 study measured Serum antibodies to squalene. In our small cohort, the substantial majority (95%) of overtly ill deployed GWS patients had antibodies to squalene.
All (100%) GWS patients immunized for service in Desert Shield/Desert Storm who did not deploy, but had the same signs and symptoms as those who did deploy, had antibodies to squalene. In contrast, none (0%) of the deployed Persian Gulf veterans not showing signs and symptoms of GWS have antibodies to squalene.
Neither patients with idiopathic autoimmune disease nor healthy controls had detectable serum antibodies to squalene. The majority of symptomatic GWS patients had serum antibodies to squalene.
1993. Clinton placed access to childhood vaccines at the forefront of his administration’s health reform efforts, moved in part by the measles epidemics of the preceding years and in part by public health officials’ conclusions about the cause of the epidemics.
The Comprehensive Child Immunization Act he signed into law in 1993 created an entitlement program, Vaccines for Children (VFC), to provide free vaccines for all Native American and Alaska Native children, children without insurance, children covered by Medicaid, and children whose insurance did not cover vaccines.
The Clinton administration had initially proposed a universal purchase program to provide free vaccines for all US children; the program approved by Congress was a compromise, but it helped bring toddler immunization rates to once-again historic heights by the end of Clinton’s first term and soon eliminated racial disparities in MMR vaccination rates.
Clinton’s last year in office would go down in public health history as the year measles was officially “eliminated” from the United States: the disease was no longer endemic, and the only remaining cases were imported from abroad or spread by such cases.
From the 1990s to the early 2000s, vaccines against hepatitis B, rotavirus, Haemophilus influenzaetype b, pneumococcal disease, influenza, chicken pox, hepatitis A, meningococcal disease, and human papillomavirus were added to the list of routine immunizations recommended by the federal Advisory Committee on Immunization Practices, which guides state mandates.
At first in chat rooms, and then later on blogs and social media, parents began to ask questions that echoed the questions of parents a generation before. Wasn’t chicken pox a harmless part of childhood? Why were their children being vaccinated against diseases they had never heard of? Why were they being vaccinated against diseases that would not spread in the classroom? And given all the negative publicity being directed toward drug companies, were all of these new vaccines assuredly safe?
The Institute of Medicine convened a committee to review these concerns from 2001 through 2004. But in media coverage of vaccine fears, just one story, the link between vaccines and autism, prevailed.
Autism rates had climbed to unfathomable heights, a single study published in the prestigious journal The Lancethad proposed a connection to the MMR vaccine, and it was easy to find heartbreakingly worried parents of autistic children who believed in the connection, celebrities who endorsed it, and physicians who vehemently denied i
1993-The Urrabe strain measles mumps rubella (“MMR”) vaccine was introduced in Canada in the early 1980’s and withdrawn immediately because it caused aseptic meningitis. Despite the warning, Britain introduced the same shot and withdrew it in 1993 for the same reason.
In 1994, researchers at the Swiss National Center for Retroviruses, University of Zurich, Switzerland reported the development of an ultrasensitive assay for RT, called Product Enhanced Reverse Transcriptase (PERT), which is at least a million-fold more sensitive than the standard assay .
The first PERT assay, and then variants of it developed independently by others, was used to examine vaccine cell substrates and vaccine samples for RT activity.
Results showed the presence of low levels of RT activity in some vaccines derived from chicken cells, notably MMR vaccine produced by Merck, and yellow fever vaccine.
There was evidence for the presence of both Endogenous Avian Virus(EAV) and Avian Leukosis Virus(ALV)-related sequences associated with the particles.
1994 study indicated that as vaccination rates increased, measles became a disease of vaccinated people. This “startling” surprise challenged the theory that vaccine-induced “herd immunity” would protect against outbreaks of measles. …multiple measles outbreaks have occurred in school populations in which 71% to 99.8% of the student body had been vaccinated appropriately…
Startling at the time was the finding that measles outbreaks developed in these school populations even though more than 98% of the students had previously been vaccinated…
In the particular case of measles, “herd immunity” is not completely effective in preventing an outbreak of measles despite extraordinarily high immunization rates.
As always happens after a vaccine campaign, the criteria for diagnosing the disease was narrowed. The vaccinated who developed measles were not counted in the tally of wild measles, even though they were infected with measles virus.
The accelerated decline seen on the curve could have been due to the fact that if someone received a vaccine and developed a rash and high fever, but did not have wild-type measles, it wasn’t measles.
So because of the new classification, measles was bound to drop in the vaccinated. The CDC admits today that: …many measles cases in previously vaccinated or immunosuppressed individuals do not meet the clinical case definition.
Modern clinical case confirmation criteria are very stringent: Laboratory confirmation by any of the following
Positive serologic test for measles immunoglobulin M antibody; Significant rise in measles antibody level by any standard serologic assay; Isolation of measles virus from a clinical specimen; or Detection of measles-virus specific nucleic acid by polymerase chain reaction
Note: A laboratory-confirmed case does not have to have generalized rash lasting ≥ 3 days; temperature ≥ 101 ° F or 38.3 ° C; cough, coryza, or conjunctivitis.
OR
An illness characterized by Generalized rash lasting ≥ 3 days; and Temperature ≥ 101 ° F or 38.3 ° C; and Cough, coryza, or conjunctivitis; and Epidemiologic linkage to a confirmed case of measles.
Serologic verification and contact with another verified case was not necessary before the vaccination era,even though there are at least 10 other infections that clinically resemble measles.
Today there are numerous reports of missed diagnoses in the vaccinated because it is assumed they don’t have measles; therefore only the differential diagnoses are considered.
1995-The discovery of reverse transcriptase(RT) activity in marketed measles, mumps and rubella(MMR) vaccine raised concerns that the vaccine was contaminated by an unrecognized avian retrovirus with unknown safety implications.
Regulatory requirements for measles and mumps vaccines in stipulated that chicken cells used in production should be free from infectious avian retroviruses. All licensed vaccines produced in chicken cells would therefore have been tested for the presence of avian retroviruses.
It was concluded that the presence of RT activity, especially at the very low levels detected by the novel ultrasensitive assays involving PCR was insufficient to prove contamination by an infectious avian retrovirus.
1995-the CDC hired a PhD computer analytics expert, Dr. Gary Goldman, to perform the largest-ever CDC-funded study of the chickenpox vaccine.
Goldman’s results on an isolated population of 300,000 residents of Antelope Valley, California, showed that the vaccine waned, leading to dangerous outbreaks of chickenpox in adults and that ten-year-old children who received the vaccine were getting shingles at over three times the rate of unvaccinated children.
Shingles has twenty times the death rate of chickenpox and causes blindness. CDC ordered Goldman to hide his findings and forbade him from publishing his data.
In 2002, Goldman resigned in protest. He sent a letter to his bosses saying that he was resigning because “I refuse to participate in research fraud.”
1996, government researchers identified SV-40 in 23 percent of the blood specimens and 45 percent of the sperm specimens collected from healthy adults. Six percent of the children born between 1980 and 1995 are infected.
Public health officials gave millions of people the vaccine for years after they knew it was infected. They contaminated humanity with a monkey virus and refused to admit what they’d done. Today, SV-40 is used in research laboratories throughout the world because it is so reliably carcinogenic.
In 1998 British researcher Andrew Wakefield, along with 12 co-authors, published a paper in the Lancetclaiming evidence of measles virus in the digestive systems of autistic children. In press conferences after the paper was published, Wakefield suggested a relationship between the MMR (measles, mumps and rubella) vaccine and autism.
Wakefield then recommended that the combination MMR vaccine be suspended in favor of single-disease vaccinations given separately over time.
Vaccination rates in England dropped in response, from more than 90% to 80% or lower—well below the level required for herd immunity to measles. Measles cases, meanwhile, began to rise: while only 56 cases were confirmed in Wales and England in 1998, 1,348 were confirmed by 2008.
In 2004, it was reported that some of the subjects of Wakefield’s paper had been recruited by a lawyer involved in a lawsuit against vaccine manufacturers; in response to this and other problems with the paper, 10 of the 12 co-authors eventually retracted the interpretation regarding a link between the vaccine and autism.
Numerous epidemiological studies performed since have also provided additional evidence that no such link exists. In 2010, Britain’s General Medical Council ruled that Wakefield had engaged in misconduct during the course of conducting and publishing the study.
Subsequently, the Lancetformally retracted the paper; in May 2010, Wakefield was banned from practicing medicine in Britain.
It should be noted that the other author whose licensed was pulled took the General Medical Council to court and their decision was overturned. Wakefield did not contest the decision because his insurance would not cover the legal expenses
1998, some research caused concern that hepatitis B vaccination might be linked with multiple sclerosis (MS), a progressive nerve disease. However, this link has not been found in the large body of research that has been done since that time.
1998, the FDA approved RotaShield vaccine, the first vaccine to prevent rotavirus gastroenteritis. Shortly after it was licensed, some infants developed intussusception (rare type of bowel obstruction that occurs when the bowel folds in on itself) after being vaccinated.
At first, it was not clear if the vaccine or some other factor was causing the bowel obstructions. CDC quickly recommended that use of the vaccine be suspended and immediately started two emergency investigations to find out if receiving RotaShield vaccine was causing some of the cases of intussusception.
The results of the investigations showed that RotaShield vaccine caused intussusception in some healthy infants younger than 12 months of age who normally would be at low risk for this condition.
There were concerns that the meningococcal vaccine Menactra caused a serious neurological disorder called Guillain-Barré Syndrome (GBS).
Between 2005 and 2008, there were a number of youth who reported GBS after receiving Menactra. However, to investigate whether GBS was caused by the vaccine or was coincidental with vaccination, two large studies were conducted, with a combined total of over 2 million vaccinated adolescents. The results of these studies showed that there was no link between Menactra and GBS.
1999-The first vaccine for rotavirus, a common cause of severe childhood diarrheal illness, RotaShield, was licensed and recommended for routine childhood immunization in 1998.
Wyeth Pharmaceuticals, however, withdrew the vaccine in 1999 due to safety concerns. Scientists associated the vaccine with a rare intestinal problem called intussusception, a potentially fatal telescoping of part of the bowel.
1999-On June 17, 1999, the Advisory Committee for [ sic ] Immunization Practices (ACIP) voted to change the recommendation for routine childhood polio vaccination beginning in 2000 to a schedule using only the inactivated poliovirus vaccine (IPV) to eliminate the occurrence of vaccine-associated paralytic poliomyelitis (VAPP) in the United States. . . . The committee voted that oral polio vaccine will be acceptable only in special circumstances.
Since 1979, the only cases of polio disease in the United States have been caused by the oral polio vaccine (OPV) which had been used routinely for childhood vaccination since 1965.
1999, the journal Anticancer Research published findings in an article titled “Cancer risk associated with simian virus 40 contaminated polio vaccine.” Carbone’s name is listed as one of three names on the paper.
The circumspect tone of the authors fails to mute the horrifying results: Our analysis indicates increased rates of ependymomas (37%), osteogenic sarcomas (26%), other bone tumors (34%) and mesothelioma (90%) among those in the exposed as compared to the unexposed birth cohort. . . .
These data suggest that there may be an increased incidence of certain cancers among the 98 million persons exposed to contaminated polio vaccine in the US; further investigations are clearlly warranted
2000 -the Simpsonwood Conference was held for the top vaccine experts discussing serious findings of Dr Verstraeten from the CDC who analyzed vaccine and autism data from the Vaccine Safety Datalink . At the Simpsonwood conference Verstraeten was criticized for doing the study as he should have known he would find an association between autism and thimerosal. Dont Look, Dont Find.
Verstraeten eventually published his findings after extensive massage to remove the disturbing findings. He denies he “watered down” the original results to become neutral in that after the Simpson Conference what was then a clear association could now neither be confirmed nor refuted, and would require more more study.
2002-FDA isolate, silence, and drives from government service its star epidemiologist, Dr. Bart Classen, when his massive epidemiologic studies, the largest ever performed, linked Hib vaccines to the juvenile diabetes epidemic.
FDA ordered Dr. Classen to refrain from publishing the government-funded studies, forbade him from talking publicly about the alarming outbreak, and eventually forced him out of government service.
2002 MenAfriVac campaign in Sub-Saharan Africa, Gates’ operatives forcibly vaccinated thousands of African children against meningitis. Approximately 50 of the 500 children vaccinated developed paralysis. South African newspapers complained, “We are guinea pigs for the drug makers.” Nelson Mandela’s former Senior Economist, Professor Patrick Bond, describes Gates’ philanthropic practices as “ruthless and immoral.”
2005- The NVICP began covering injuries resulting from trivalent influenza vaccines in 2005, expanding its coverage to all seasonal influenza vaccines in 2013..
By 2010, influenza vaccination had become a prevalent catalyst for vaccine injury petitions to the NVICP, and by 2015, it was the dominant vaccine in the Program for injuries and death, accounting for more than seven out of ten petitions filed.
Influenza vaccination is the very reason why the program designed by Congress as a National Vaccine Injury Compensation Program is no longer primarily for children’s injuries but has become a program where compensation is more often for adult vaccine injuries.
Today, the most common severe injuries reported following influenza vaccination are “shoulder injury related to vaccine administration” (SIRVA), Guillain-Barré syndrome (GBS), transverse myelitis (TM), chronic inflammatory demyelinating polyneuropathy (CIDP), acute disseminated encephalomyelitis (ADEM) and death.
As of mid-March 2020, the total NVICP payout for all injuries and death from seasonal influenza vaccines was approximately $897,967,381.38 for the last 15 years (based on analysis of all decisions posted at the United States Court of Federal Claims website).
Over 2,000 influenza petitions alone are pending as of 2020. Not even a year ago, that figure was 50% less.
2006-Dr. Stephen Walker’s group in a preliminary report in 2006. Vaccine-strain measles was found in the bowel lesions of his series of autistic children.That work stalled due to lack of funding.
A Japanese group published results showing that vaccine-strain measles is found in peripheral blood mononuclear cells. The group carried out detection of measles genomic RNA in peripheral mononuclear cells in eight patients with Crohn’s disease, three patients with ulcerative colitis, and nine children with autistic enterocolitis.
The sequences obtained from the patients with ulcerative colitis and children with autism were consistent with vaccine strains.
2006-a large Mumps outbreakoccurred among highly vaccinated populations in the United States with similar outbreaks reported worldwide.
Eighty-nine percent of those who contracted mumps had already been vaccinated at least twice for the disease,presumably with the controversial measles, mumps, and rubella combination vaccine that has been implicated in causing gastrointestinal disorders and autism.
These numbers indicate that the MMR vaccine was, in this case, essentially ineffective in preventing the disease, and offer strong support to parents who would think twice about administering this vaccine to their children.
2006, Dr. Zimmerman was a co-author of a case study about a 19-month-old girl who developed ASD symptoms shortly following vaccination. The girl’s family went public with her story in 2008, revealing her name to be Hannah Poling, the daughter of a pediatric neurologist who co-authored the 2006 report with Zimmerman.
Later testing, the case study reported, revealed that the girl suffered from pre-existing mitochondrial disorders, a suite of conditions that affect a cell’s ability to use energy properly. In an effort to test the notion that autism is commonly associated with such disorders, the researchers did a retrospective review of autism cases, finding some evidence in support of such an association.
Based on that retrospective review, the authors of the 2006 study speculated that “Young children who have dysfunctional cellular energy metabolism … might be more prone to undergo autistic regression between 18 and 30 months of age if they also have infections or immunizations at the same time.”
2007- Dr Zimmerman, a pediatric neurologist who studies autism spectrum disorders, initially submitted testimony regarding the case Cedillo v. Secretary of Health and Human Services, in which DOJ stated his expert view was “there is no evidence of an association between autism and the alleged reaction to MMR and [Mercury].”
Dr. Zimmerman said he told Department of Justice (DOJ) lawyers that he wanted to add one narrow and specific exception to his original statement (our emphasis): “that there may be a subset of children who are at risk for [developmental] regression if they have underlying mitochondrial dysfunction and are simultaneously exposed to factors that stress their mitochondrial reserve.”
Zimmerman maintained that after informing the DOJ of his revised opinion three days before his scheduled testimony, DOJ lawyers asked him “not to testify”.
He later learned that his original opinion, without the mitochondrial dysfunction modifier, was cited as evidence in both the Cedillo case as well another case: Hazlehurst v. Secretary of Health and Human Services, a test case for the alleged ‘thimerosal and MMR combined’ autism mechanism.
The setup of the Omnibus Autism Proceeding was that the five test cases including Cedillo would stand in for the more than five thousand claims that had been filed. Poling was supposed to have been the first, but it was settled prior to the start of the proceeding.
As a result of DOJ deception, 5000 claimants received nothing. Contrast that with Dr Polings award. 20 million x 5000 = 100 billion
2007, Merck & Company, Inc. voluntarily recalled 1.2 million doses of Haemophilus influenzae type b (Hib) vaccines due to concerns about potential contamination with bacteria called B. cereus. The recall was a precaution, and after careful review, no evidence of B. cereus infection was found in recipients of recalled Hib vaccines.
2009-An increased risk of narcolepsy (a chronic sleep disorder) was found following vaccination with Pandemrix, a monovalent 2009 H1N1 influenza vaccine that was used in several European countries during the H1N1 influenza pandemic.
This risk was initially found in Finland, and then some other European countries also detected an association.
Pandemrix is manufactured by GlaxoSmithKline in Europe and was specifically produced for pandemic 2009 H1N1 influenza. Pandemrix was never licensed for use in the United States.
2009-Dr. Douglas Kerr from Johns Hopkins stated in his foreword to The Autoimmune Epidemic published in 2009: Infants as young as five months old can get transverse myelitis, and some are left permanently paralyzed and dependent upon a ventilator to breathe… my colleagues at the Johns Hopkins Hospital and I hear about or treat hundreds of new cases every year.
Does the public have any idea that there are hundreds of cases of something that is now called transverse myelitis that would have historically been called polioand is now leaving children permanently dependent on a modern version of the iron lung?
Approximately 33,000 people are afflicted by transverse myelitis in the United States, with 1,400 new cases per year. This would have been called polio in the years leading up to 1954.
2009: The Gates Foundation funds human papillomavirus (HPV) vaccine trials in India, administering the vaccine to 23,000 young girls in remote provinces. Seven die and approximately 1,200 suffer autoimmune conditions, fertility disorders or other severe reactions. Ethical violations include forged consent forms and refusal of medical treatment for the injured girls.
2010-it was reported the family of Hannah Poling will receive more than$1.5 million dollars for her life care; lost earnings; and pain and suffering for the first year alone.
In addition to the first year, the family will receive more than $500,000 per year to pay for Hannah's care. Those familiar with the case believe the compensation could easily amount to $20 million over the child's lifetime.
Hannah is the daughter of Neurologist Jon Poling, MD, PhD.
Dr Zimmermans 2006 study formed the basis of the Poling families case and Dr Poling was coauthor
They do take care of their own, don’t they
2010-Porcine circovirus (PCV) is a common virus found in pigs. In 2010, it was discovered that both rotavirus vaccines licensed in the U.S.- Rotarix and RotaTeq- contained PCV type 1.
PCV1 is not known to cause disease in animals or humans.
FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) convened to discuss the findings of PCV and PCV DNA in rotavirus vaccines.
The committee advised the FDA that the benefit/risk considerations remained in favor of continued use of both rotavirus vaccines despite the adventitious agents or sequences thereof, and that they should remain on the market in the USA, but that the companies should work towards establishing (in the case of Rotarix®) and maintaining (in the case of RotaTeq®) vaccines free from PCV as rapidly as feasible and prudently possible.
2010-2010-CDC-funded study by Harvard Pilgrim found that less than 1% of the post-vaccination adverse events recorded by doctors in their own medical records were ever reported to VAERS.
. Preliminary data were collected from June 2006 through October 2009 on 715,000 patients, and 1.4 million doses (of 45 different vaccines) were given to 376,452 individuals.
Of these doses, 35,570 possible reactions (2.6 percent of vaccinations) were identified. This is an average of 890 possible events, an average of 1.3 events per clinician, per month. These data were presented at the 2009 AMIA conference.
In addition, ESP:VAERS investigators participated on a panel to explore the perspective of clinicians, electronic health record (EHR) vendors, the pharmaceutical industry, and the FDA towards systems that use proactive, automated adverse event reporting.
Adverse events from drugs and vaccines are common, but underreported. Although 25% of ambulatory patients experience an adverse drug event, less than 0.3% of all adverse drug events and 1-13% of serious events are reported to the Food and Drug Administration (FDA).
Likewise, fewer than 1% of vaccine adverse events are reported. Low reporting rates preclude or slow the identification of “problem” drugs and vaccines that endanger public health.
New surveillance methods for drug and vaccine adverse effects are needed. Barriers to reporting include a lack of clinician awareness, uncertainty about when and what to report, as well as the burdens of reporting: reporting is not part of clinicians’ usual workflow, takes time, and is duplicative.
Proactive, spontaneous, automated adverse event reporting imbedded within EHRs and other information systems has the potential to speed the identification of problems with new drugs and more careful quantification of the risks of older drugs.
Unfortunately, there was never an opportunity to perform system performance assessments because the necessary CDC contacts were no longer available and the CDC consultants responsible for receiving data were no longer responsive to our multiple requests to proceed with testing and evaluation.
2010, two former Merck scientists,, filed suit under the False Claims Act. The filing accuses Merck of lying about the safety and effectiveness of MMR vaccines, tampering with study data, defrauding the U.S. government and various other high-level crimes.
They allege Merck senior management falsified data specifically on the effectiveness of the mumps vaccine, intentionally spiking blood samples with animal antibodies in order to trick the FDA into thinking that the vaccine is effective.
The only way Merck was able to gain a monopoly for the MMR in the US was by demonstrating to the FDA that the mumps vaccine is at least 95 percent effective.
2010, the Gates Foundation funded a trial of a GSK’s experimental
malaria vaccine, killing 151 African infants and causing serious
adverse effects including paralysis, seizure, and febrile convulsions
to 1,048 of the 5,049 children.
2011-Implementation of the National Vaccine Plan was accelerated in 2011 after the U.S. Supreme Court declared FDA licensed vaccines to be –quote – “unavoidably unsafe”“unavoidably unsafe” for the purpose of removing almost all remaining liability from drug companies when vaccines hurt people.
Since 2011, two powerful CDC-appointed vaccine advisory committees influenced by members associated with the pharmaceutical and medical trade industries – the Advisory Committee on Immunization Practices (ACIP) and the National Vaccine Advisory Committee (NVAC) – have been busy coming up with new ways to meet strategic goals of the National Vaccine Plan.
2012 study by Dr. Witt and colleagues showed that the majority of children who had whooping cough—as confirmed by laboratory testing—had been vaccinated.
Of the 132 patients 18 years of age or under at time of illness, 81% were fully vaccinated, 11% under-vaccinated, and 8% never vaccinated. Of the 103 individuals 12 years of age or younger 85% were fully vaccinated, 7% under-vaccinated, and 8% never vaccinated.
Contrary to broad medical belief, the disease did not strike the unvaccinated more than the vaccinated as is generally expected by vaccine proponents.
2013, Merck & Company, Inc. recalled one batch of Gardasil, a human papillomavirus (HPV) vaccine. The recall was a precaution following an error in the manufacturing process. The company had concerns that a small number of vials might have contained glass particles due to breakage.
No health problems were reported relating to this recall other than known side effects that can result from any vaccination, like arm redness and soreness where the shot was given.
2013 pertussis-like infections amounted to nearly 50,000 cases in the United States in 2013, the most since 1955, almost all affecting people who had previously been vaccinated
2014, Kenya’s Catholic Doctors Association accused the WHO of chemically sterilizing millions of unwilling Kenyan women with a “tetanus” vaccine campaign. Independent labs found a sterility formula in every vaccine tested. After denying the charges, WHO finally admitted it had been developing the sterility vaccines for over a decade. Similar accusations came from Tanzania, Nicaragua, Mexico, and the Philippines.
2014, the Gates Foundation funded tests of experimental HPV vaccines, developed by Glaxo Smith Kline (GSK) and Merck, on 23,000 young girls in remote Indian provinces. Approximately 1,200 suffered severe side effects, including autoimmune and fertility disorders. Seven died. Indian government investigations charged that Gates-funded researchers committed pervasive ethical violations: pressuring vulnerable village girls into the trial, bullying parents, forging consent forms, and refusing medical care to the injured girls. The case is now in the country’s Supreme Court.
In 2014, CDC published a study on the association between 2009 H1N1 influenza vaccines, 2010/2011 seasonal influenza vaccines, and narcolepsy.
The study found that vaccination was not associated with an increased risk for narcolepsy.
In 2018, a study team including CDC scientists analyzed and published vaccine safety data on adjuvanted pH1N1 vaccines (arenaprix-AS03, Focetria-MF59, and Pandemrix-AS03) from 10 global study sites. Researchers did not detect any associations between the vaccines and narcolepsy.
2014, August 27 CDC Vaccine-Researcher-Turned-Whistleblower Dr. William Thompson, Ph.D. whistleblower releases statement through his lawyers, stating, among other things:
“I regret that my coauthors and I omitted statistically significant information in our 2004 article published in the journal Pediatrics. The omitted data suggested that African American males who received the MMR vaccine before age 36 months were at increased risk for autism. Decisions were made regarding which findings to report after the data were collected, and I believe that the final study protocol was not followed.”
He was denied the ability to testify in 2016 regarding scientific fraud and destruction of evidence by senior CDC officials in critical CDC vaccine safety studies regarding an association between childhood vaccines and autism. Thompson invoked federal whistleblower status and alleges that the CDC destroyed evidence that black boys are 3.36 times more likely to develop autism if they receive the MMR vaccine before age three. Despite Thompsons confession and allegations the paper publishing the fraudulent study has never bern retracted. No Wakefield treatment for CDC and pro-vaccine studies.
On 27 August 2014, Dr. Hooker’s article published in the journal Translational Neurodegeneration that concluded “African American males receiving the MMR vaccine prior to 24 months of age or 36 months of age are more likely to receive an autism diagnosis” was removedfrom public domain due to issues of conflict of interest and the questionable validity of its methods
2014 study in Biologicals.. We have selected four instances where an adventitious agent, or a signal suggesting the presence of an agent, was found in a viral vaccine, and have developed a case study for each. The four cases are: a) SV40in polio vaccines; b) bacteriophage in measles and polio vaccines; c) reverse transcriptasein measles and mumps vaccines; and d) porcine circovirusand porcine circovirus DNA sequences in rotavirus vaccines.
2017, the World Health Organization (WHO) reluctantly admitted that the global explosion in polio is predominantly vaccine strain. The most frightening epidemics in Congo, Afghanistan, and the Philippines, are all linked to vaccines. In fact, by 2018, 70% of global polio cases were vaccine strain.
A 2017 study (Morgenson et. al. 2017) showed that WHO’s popular DTP vaccine is killing more African children than the diseases it prevents. DTP-vaccinated girls suffered 10x the death rate of children who had not yet received the vaccine. WHO has refused to recall the lethal vaccine which it forces upon tens of millions of African children annually.
2019, the FDA approved a dengue vaccine for U.S. children, undaunted by its track record in the Philippines, where the vaccine triggered hundreds of pediatric hospitalizations and deaths.